Latest filing published 05 Dec 2025 for Sana Biotechnology, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Susan D. Wyrick across 2 companies, led by Sana Biotechnology, Inc. and Achieve Life Sciences, Inc. The record holds 27 filings, for trades running from 13 August 2013 to 9 March 2026.
No open-market purchase appears, only 3 sales worth €4,136. The rest of the record consists of 11 share grants and 13 option exercises.
On 10 March 2026 came the latest disclosure, an option exercise in Sana Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations